Cormorant Asset Management’s Eledon Pharmaceuticals ELDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,217,882
| Closed | -$2.87M | – | 65 |
|
|
2023
Q1 | $2.87M | Hold |
1,217,882
| – | – | 0.19% | 57 |
|
|
2022
Q4 | $2.78M | Sell |
1,217,882
-5,618
| -0.5% | -$12.8K | 0.19% | 58 |
|
|
2022
Q3 | $3.38M | Sell |
1,223,500
-81,595
| -6% | -$225K | 0.24% | 54 |
|
|
2022
Q2 | $3.18M | Hold |
1,305,095
| – | – | 0.24% | 57 |
|
|
2022
Q1 | $5.14M | Hold |
1,305,095
| – | – | 0.39% | 51 |
|
|
2021
Q4 | $5.76M | Hold |
1,305,095
| – | – | 0.34% | 54 |
|
|
2021
Q3 | $8.07M | Sell |
1,305,095
-110,405
| -8% | -$682K | 0.33% | 59 |
|
|
2021
Q2 | $11.2M | Hold |
1,415,500
| – | – | 0.38% | 55 |
|
|
2021
Q1 | $15.1M | Hold |
1,415,500
| – | – | 0.34% | 54 |
|
|
2020
Q4 | $21.4M | Buy |
+1,415,500
| New | +$21.4M | 0.51% | 42 |
|